OmniCyte Ltd is a British-based biotechnology company specialising in extracting the therapeutic potential and benefits of stem cell technologies.

We aim to deliver reagents for the treatment of a range of debilitating conditions in humans, including Parkinson's disease, stroke, cirrhosis, diabetes and ischaemic heart disease. This will be achieved using proprietary knowledge and methods that all include re-infusion of autologous cells.

Please contact OmniCyte Ltd for any further information that is not found on this site.

<< This is a beta-version of the web site;
additions and amendments are being made to it >>

OmniCyte Ltd
Stem cell science